Main > MEDICINE > HyperEosinophilic Syndrome > Treatment > MepolizuMAb (IL-5 Inhibitor) > Co.: UK. G. (Phase III)

---

Co.: UK. G. (Phase III)'s subsections
Company
TradeMark
UpDate: 03.14.08. (Press Release)

Co.: UK. G. (Phase III)'s products
This section has no products